| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TDRD1 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.006 |
| mRNA | OR1J2 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.006 |
| mRNA | MIS18A | CTRPv2 | pan-cancer | AAC | 0.33 | 0.006 |
| mRNA | CYB561D2 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.006 |
| mRNA | SDC4 | CTRPv2 | pan-cancer | AAC | -0.44 | 0.006 |
| mRNA | CD101 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | ATG16L2 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.006 |
| mRNA | CAMTA1 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | RFC4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.006 |
| mRNA | RP11-26J3.4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.006 |
